← Back to Clinical Trials
Recruiting NCT06861608

NCT06861608 A Single-session Intervention Adaptation of the Habit Framework for the Prevention of Eating Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06861608
Status Recruiting
Phase
Sponsor Virginia Commonwealth University
Condition Eating Disorder Not Otherwise Specified
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2025-01-15
Primary Completion 2026-07-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 22 Years
Study Type INTERVENTIONAL
Interventions
Screening QuestionnairePre-Intervention Questionnaires (~10 minutes)SSI (Single-session intervention (~30 minutes) Active arm

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2025-01-15 with a primary completion date of 2026-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this proposal is to launch the first trial of a single-session intervention (SSI) specifically for the prevention of eating disorders (EDs).

Eligibility Criteria

Inclusion Criteria: * EAT-26 score ≥ 20 ( EAT-26, participants will meet the "referral criteria" which includes a score of 20 or more or meeting frequency criteria on bingeing, purging, laxative/diuretic use, and/or exercise.) * English-language fluency, self-reported3 * Access to a phone, tablet, or computer Exclusion Criteria: * Failure to correctly complete one of the attention checks in the survey prior to the intervention * Failure to correctly complete both anagram tasks in the survey prior to the intervention * Completion of the screening survey or pre-intervention surveys in an improbably fast time

Contact & Investigator

Central Contact

Courtney Breiner

✉ breinerc@vcu.edu

📞 518-376-2543

Principal Investigator

Courtney Breiner

PRINCIPAL INVESTIGATOR

Virginia Commonwealth University

Frequently Asked Questions

Who can join the NCT06861608 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 22 Years, studying Eating Disorder Not Otherwise Specified. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06861608 currently recruiting?

Yes, NCT06861608 is actively recruiting participants. Contact the research team at breinerc@vcu.edu for enrollment information.

Where is the NCT06861608 trial being conducted?

This trial is being conducted at Richmond, United States.

Who is sponsoring the NCT06861608 clinical trial?

NCT06861608 is sponsored by Virginia Commonwealth University. The principal investigator is Courtney Breiner at Virginia Commonwealth University. The trial plans to enroll 160 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology